The New York Times’ Post

View organization page for The New York Times, graphic

6,824,734 followers

Pharmacy benefit managers — like CVS Caremark, Optum Rx and Express Scripts — act as middlemen overseeing prescriptions for more than 200 million Americans. They’re meant to reduce drug costs. But instead, they steer patients toward pricier drugs, charge steep markups on otherwise inexpensive medicines and extract billions in hidden fees, a New York Times investigation found.

The Opaque Industry Secretly Inflating Prices for Prescription Drugs

The Opaque Industry Secretly Inflating Prices for Prescription Drugs

https://www.nytimes.com

Anne Sonnier

Garden Associate at The Home Depot

1w

Glad I only take one med which costs 40 a year. Others not so lucky.

Like
Reply
Robby Remlinger

Too clever is dumb; three clever is dumbfounded.

1w

This needs a slogan, I'm thinking: "NO MORE TIERS" It should sound familiar enough to consumers. https://www.johnsonsbaby.com/baby-products/johnsons-baby-shampoo Johnsons is owned by Kenvue Inc. is owned by Johnson & Johnson (JNJ).

Sam Eller

Associate Advisor | Employee Health & Benefits

1w

NYT shining some light on PBM's!

Mark Nichols

Manager - Data Journalism at ABC News

1w

Insightful reporting here!❤️

Kristi Kloss

Artist Metalsmith & Nature Nerd

1w

Freakonomics also did an episode on this. Big pharma has a co-conspirator.

Manana Tagle

Profesional independiente en el sector Traducción y localización

1w

Enfuriating practice!

See more comments

To view or add a comment, sign in

Explore topics